Calendar Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Market Closed - Nyse 04:00:00 2024-03-01 pm EST 5-day change 1st Jan Change
1.11 USD +6.73% Intraday chart for Lineage Cell Therapeutics, Inc. +7.77% +1.83%

Chart calendar Lineage Cell Therapeutics, Inc.

c96546e85.COOqYn8MuzhkviVQeX1SG_hu5ut6eyM1-TV7Eh9SMsE.Q7PhCQlu838K_AgiSQw4bZM5jIIrC0QBiHwLP2sncZh5re0XG0TRbDTtFQ~f6e82d3ea2d80fa540e593b704e2253a

Upcoming events on Lineage Cell Therapeutics, Inc.

2024-03-13 Q4 2023 Earnings Release (Projected)
2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)

Past events on Lineage Cell Therapeutics, Inc.

2023-11-09 04:30 pm Q3 2023 Earnings Call
2023-11-09 04:01 pm Q3 2023 Earnings Release
2023-10-04 EURETINA Congress
2023-09-27 09:10 am Cantor Global Healthcare Conference
2023-09-16 11:10 am International Spinal Research Trust Network Meeting
2023-09-14 11:50 am International Spinal Research Trust Network Meeting
2023-09-13 10:30 am H.C. Wainwright Global Investment Conference
2023-09-12 12:50 pm Baird Global Healthcare Conference
2023-08-10 04:30 pm Q2 2023 Earnings Call
2023-08-10 04:01 pm Q2 2023 Earnings Release
2023-06-28 Spinal Cord Injury Investor Symposium
2023-06-20 01:30 pm Maxim Group Virtual Healthcare Conference
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:01 pm Q1 2023 Earnings Release
2023-04-25 02:30 pm Association for Research in Vision and Ophthalmology Meeting
2023-04-25 10:00 am American Association of Pharmaceutical Scientists National Biotechnology Conference - Panel
2023-04-20 Fighting Blindness Foundation and Casey Eye Institute Retinal Cell and Gene Therapy Innovation Summi
2023-03-09 04:30 pm Q4 2022 Earnings Call
2023-03-09 04:01 pm Q4 2022 Earnings Release
2022-12-08 01:45 pm Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference

Past dividends on Lineage Cell Therapeutics, Inc.

2018-11-28 0 USD
2016-01-03 0

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
4,99
4,90
1.83%
3,52
2,88
21.88%
1,83
2,17
-15.84%
4,34
3,76
15.58%
14,7
15,3
-4.09%

9,70

EBITDA
Million USD
Released
Forecast
Spread
-41,8
-42,6
1.89%
-35,7
-40,8
12.28%
-24,3
-27,5
11.51%
-48,3
-28,4
-69.99%
-21,8
-20,1
-8.58%

-25,8

EBIT
Million USD
Released
Forecast
Spread
-41,8
-40,8
-2.32%
-38,9
-40,4
3.69%
-26,4
-29,4
10.04%
-49,2
-29,7
-65.71%
-22,5
-22,3
-0.89%

-24,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-47,1
-10,8
-337.56%
-19,2
-22,9
16%
-21,9
-29,5
25.69%
-43,3
-25,6
-69.14%
-25,8
-26,0
0.7%

-24,3

Net income
Million USD
Released
Forecast
Spread
-46,0
-10,1
-355.15%
-11,7
-15,9
26.31%
-20,6
-30,4
32.12%
-43,0
-24,8
-73.38%
-26,3
-26,3
0.18%

-22,9

EPS
USD
Released
Forecast
Spread
-0,36
-0,08
-350%
-0,08
-0,11
25%
-0,14
-0,20
30%
-0,26
-0,14
-80.56%
-0,15
-0,15
2.17%

-0,13

Announcement Date14/03/1912/03/2011/03/2110/03/2209/03/23-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,90
1,27
-29.13%
2,27
0,51
345.1%
1,17
0,64
83.65%
5,24
8,90
-41.17%
4,55
4,95
-7.96%
3,00
4,31
-30.49%
1,92
2,54
-24.61%
2,39
2,01
18.62%
3,23
2,19
47.35%
1,25
2,65
-52.98%

2,84


0,62


0,19


0,19


15,9

EBITDA
Million USD
Released
Forecast
Spread
-11,9
-14,9
20.2%
-6,64
-7,05
5.76%
-28,0
-7,79
-260.04%
-6,21
5,55
-211.96%
-4,06
-5,45
25.53%
-5,06
-3,97
-27.57%
-6,47
-4,75
-36.13%
-6,47
-6,68
3.13%
-4,85
-6,43
24.45%
-6,53
-5,13
-27.4%

-7,40













EBIT
Million USD
Released
Forecast
Spread



-6,84
-7,88
13.15%
-28,2
-8,35
-238.38%
-6,40
-9,64
33.63%
-4,23
-3,58
-18.43%
-5,25
-5,31
1.18%
-6,64
-6,43
-3.24%
-6,64
-7,49
11.34%
-5,02
-7,84
35.93%
-6,71
-6,48
-3.49%

-5,77


-8,86


-10,2


-11,0


4,59

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-15,0
-15,0
0.27%
-8,85
-7,93
-11.56%
-28,0
-8,63
-224.44%
-7,09
-7,43
4.47%
-6,78
-4,63
-46.44%
-5,58
-5,74
2.81%
-6,36
-6,50
2.1%
-6,21
-7,02
11.55%
-5,20
-7,40
29.65%
-7,16
-6,34
-12.92%

-5,79


-8,08


-10,7


-12,0


19,2

Net income
Million USD
Released
Forecast
Spread
-14,9
-15,0
0.53%
-7,82
-7,92
1.28%
-29,0
-8,59
-237.39%
-7,09
-7,43
4.55%
-6,76
-4,63
-46.11%
-6,07
-5,73
-5.9%
-6,35
-6,46
1.6%
-4,37
-7,02
37.69%
-5,23
-7,41
29.43%
-7,11
-6,33
-12.32%

-7,63


-8,03


-10,7


-11,9


19,3

EPS
USD
Released
Forecast
Spread
-0,10
-0,10
0%
-0,05
-0,05
-4.17%
-0,17
-0,05
-240%
-0,04
-0,05
20%
-0,04
-0,03
-53.85%
-0,04
-0,03
-21.73%
-0,03
-0,04
18.19%
-0,03
-0,04
21.73%
-0,03
-0,04
30.76%
-0,04
-0,04
-11.11%

-0,03


-0,04


-0,06


-0,06


0,10

Announcement Date06/08/2010/11/2110/03/2212/05/2211/08/2210/11/2209/03/2311/05/2310/08/2309/11/23-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Lineage Cell Therapeutics, Inc. - Nyse
  4. Calendar Lineage Cell Therapeutics, Inc.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW